Show results for
Refine by
Swell Equipment Supplied In Usa Massachusetts
11 equipment items found
Manufactured by:Pion based inBillerica, MASSACHUSETTS (USA)
The system's integrated fluidics and automated media switching support a variety of dosage forms, from raw drug substances to full dosage units like tablets and capsules. Quantitative assessments of swelling, disintegration, and drug release profiles are enabled with minimal material use. The device generates high-resolution 2-D videos for in-depth analysis and documentation, ...
Manufactured by:Hemedex, Inc. based inWaltham, MASSACHUSETTS (USA)
The Bowman Perfusion Monitor (BPM) (cat. #H0000-0710) is the most innovative technology of its kind. The BPM continuously quantifies tissue blood flow (perfusion) in real-time, in absolute physiological units of ...
Manufactured by:Alnylam Pharmaceuticals, Inc. based inCambridge, MASSACHUSETTS (USA)
ONPATTRO is a prescription medicine for adults that treats the polyneuropathy caused by an illness called hereditary ATTR (hATTR) ...
Manufactured by:Alnylam Pharmaceuticals, Inc. based inCambridge, MASSACHUSETTS (USA)
GIVLAARI® (givosiran) is a prescription medicine used to treat acute hepatic porphyria (AHP) in ...
by:Intellia Therapeutics, Inc. based inCambridge, MASSACHUSETTS (USA)
The first patient was dosed with our investigational genome editing treatment for transthyretin (ATTR) amyloidosis in November 2020. Our modular approach enables us to optimize the power and versatility of the CRISPR/Cas9 technology and, importantly, allows us to rapidly develop therapeutics for numerous diseases that currently have limited treatment ...
Manufactured by:Acorda Therapeutics, Inc. based inPearl River, NEW YORK (USA)
AMPYRA® (dalfampridine) Extended Release Tablets, 10 mg is a prescription medicine approved by the U.S. Food and Drug Administration (FDA) to help improve walking in adults with multiple sclerosis MS. This was demonstrated by an increase in walking speed. ...
Manufactured by:Abiomed based inDanvers, MASSACHUSETTS (USA)
The Impella RP heart pump provides temporary, circulatory support for patients who develop right heart failure. It is the only FDA-approved heart pump indicated for patients experiencing acute right heart failure or decompensation following left ventricular assist device implantation, myocardial infraction, heart transplant or open-heart ...
Manufactured by:Alkermes based inDublin 4, IRELAND
ARISTADA® (aripiprazole lauroxil) extended-release injectable suspension is a long-acting atypical antipsychotic that is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults. ARISTADA is available in four dose strengths with once-monthly dosing (441 mg, 662 mg, 882 mg), a six-week dosing option (882 mg) and a two-month dosing option (1064 ...
Manufactured by:Alkermes based inDublin 4, IRELAND
VIVITROL (naltrexone for extended-release injectable suspension) is a once-monthly medication for the treatment of alcohol dependence as well as for the prevention of relapse to opioid dependence, following opioid detoxification. Treatment with VIVITROL should be part of a comprehensive management program that includes psychosocial ...
Manufactured by:Eagle Pharmaceuticals, Inc. based inWoodcliff Lake, NEW JERSEY (USA)
Indications: BELRAPZO® (bendamustine hydrochloride injection) is indicated for the treatment of patients with chronic lymphocytic leukemia (CLL). Efficacy relative to first-line therapies other than chlorambucil has not been established. BELRAPZO® (bendamustine hydrochloride injection) is indicated for the treatment of patients with indolent B-cell non-Hodgkin lymphoma (NHL) that has ...
Manufactured by:Eagle Pharmaceuticals, Inc. based inWoodcliff Lake, NEW JERSEY (USA)
Indications: BENDEKA® is indicated for the treatment of patients with Chronic lymphocytic leukemia (CLL). Efficacy relative to first-line therapies other than chlorambucil has not been established. Indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within 6 months of treatment with rituximab or a rituximab-containing ...